G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism

A major challenge in the development of pharmacotherapies for autism is the failure to identify pathophysiological mechanisms that could be targetable. The majority of developing strategies mainly aim at restoring the brain excitatory/inhibitory imbalance described in autism, by targeting glutamate...

Descripción completa

Detalles Bibliográficos
Autores principales: DelaCuesta-Barrutia, Jon, Peñagarikano, Olga, Erdozain, Amaia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cellular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662108/
https://www.ncbi.nlm.nih.gov/pubmed/33192330
http://dx.doi.org/10.3389/fncel.2020.588662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662108/
https://www.ncbi.nlm.nih.gov/pubmed/33192330
http://dx.doi.org/10.3389/fncel.2020.588662

Ejemplares similares